MoonLake Immunotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF PARTNERS L.P.(34.6%),BVF INC.(34.6%), etc.
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merck Healthcare KGaA, Darmstadt Germany an affiliate of Merck KGaA, Darmstadt, Germany(4.7%),Merck KGaA, Darmstadt, Germany(4.7%), etc.
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%), etc.
MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bihua Chen(14.17%)
MoonLake Immunotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.419%),Abigail P. Johnson(6.419%)
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Bodenstedt Matthias
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chen Bihua
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chen Bihua
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sturge Simon
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Bodenstedt Matthias
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Santos da Silva Jorge
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian
MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chen Bihua
MoonLake Immunotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF PARTNERS L.P.(35.8%),BVF INC.(35.8%), etc.
No Data